Chemagis is a world-class developer of active pharmaceutical ingredients (API), with customers in more than 25 countries. Our research and development capabilities have resulted in numerous proprietary patents (25 granted, 50 filed).

Key products include pentoxiifylline, tramadol, midazolam, fenofibrate, fluticasone and cetirizine.

Our capabilities include:

Full current Good Manufacturing Practices (cGMP) production, from grams to multi-ton

21 US Drug Master Files (DMF), 13 European and 7 Canadian DMFs, others pending

Client-focused service

Forward integration abilities

Learn more about Chemagis at www.chemagis.com